Suppr超能文献

未透析、血液透析、持续性非卧床腹膜透析及慢性肾衰竭移植后患者的脂蛋白组成紊乱

Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure.

作者信息

Kimak Elzbieta, Ksiazek Andrzej, Solski Janusz

机构信息

Interfaculty Department of Laboratory Diagnostics, Medical University, Lublin, Poland.

出版信息

Clin Chem Lab Med. 2006;44(1):64-9. doi: 10.1515/CCLM.2006.013.

Abstract

Studies were carried out in 183 non-dialyzed, 123 hemodialysis, 81 continuous ambulatory peritoneal dialysis and 35 post-transplant patients and in 103 healthy subjects as a reference group. Lipids and apolipoprotein (apo)AI and apoB were determined using Roche kits. An anti-apoB antibody was used to separate apoB-containing apoCIII and apoE-triglyceride-rich lipoprotein (TRL) in the non-high-density lipoprotein (non-HDL) fraction from apoCIIInonB and apoEnonB in the HDL fraction in four groups of patients with chronic renal failure (CRF) and healthy subjects. Multivariate linear regression analysis was used to investigate the relationship between triglyceride (TG) or HDL-cholesterol (HDL-C) concentrations and lipoproteins. Dyslipidemia varied according to the degree of renal insufficiency, the type of dialysis and therapy regime in CRF patients. Lipoprotein disturbances were manifested by increased TG, non-HDL-C and TRL concentrations, and decreased HDL-C and apoAI concentrations, whereas post-renal transplant patients showed normalization of lipid and lipoprotein profiles, except for TG levels and total apoCIII and apoCIIInonB. The present study indicates that CRF patients have disturbed lipoprotein composition, and that hypertriglyceridemia and low HDL-C concentrations in these patients are multifactorial, being secondary to disturbed lipoproteins. The method using anti-apoB antibodies to separate apoB-containing lipoproteins in the non-HDL fraction from non-apoB-containing lipoproteins in HDL can be used in the diagnosis and treatment of patients with progression of renal failure or atherosclerosis. The variability of TG and HDL-C concentrations depends on the variability of TRL and cholesterol-rich lipoprotein concentrations, but the decreases in TG and increases in HDL-C concentrations are caused by apoAI concentration variability. These relationships, however, need to be confirmed in further studies.

摘要

对183例未透析患者、123例血液透析患者、81例持续性非卧床腹膜透析患者、35例肾移植后患者以及103例健康受试者(作为参照组)进行了研究。使用罗氏试剂盒测定血脂、载脂蛋白(apo)AI和apoB。在四组慢性肾衰竭(CRF)患者及健康受试者中,采用抗apoB抗体将非高密度脂蛋白(non-HDL)组分中含apoB的载脂蛋白CIII和apoE-富含甘油三酯脂蛋白(TRL)与高密度脂蛋白(HDL)组分中不含apoB的载脂蛋白CIII和不含apoB的载脂蛋白E分离。采用多变量线性回归分析研究甘油三酯(TG)或高密度脂蛋白胆固醇(HDL-C)浓度与脂蛋白之间的关系。CRF患者的血脂异常根据肾功能不全程度、透析类型及治疗方案而有所不同。脂蛋白紊乱表现为TG、non-HDL-C和TRL浓度升高,HDL-C和apoAI浓度降低,而肾移植后患者除TG水平以及总载脂蛋白CIII和不含apoB的载脂蛋白CIII外,血脂和脂蛋白谱恢复正常。本研究表明,CRF患者存在脂蛋白组成紊乱,这些患者的高甘油三酯血症和低HDL-C浓度是多因素的,继发于脂蛋白紊乱。使用抗apoB抗体将non-HDL组分中含apoB的脂蛋白与HDL中不含apoB的脂蛋白分离的方法可用于肾衰竭进展或动脉粥样硬化患者的诊断和治疗。TG和HDL-C浓度的变异性取决于TRL和富含胆固醇脂蛋白浓度的变异性,但TG降低和HDL-C升高是由apoAI浓度变异性引起的。然而,这些关系需要在进一步研究中得到证实。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验